8.65
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EVH Giù?
Forum
Previsione
Precedente Chiudi:
$8.48
Aprire:
$8.53
Volume 24 ore:
2.89M
Relative Volume:
1.22
Capitalizzazione di mercato:
$1.08B
Reddito:
$2.35B
Utile/perdita netta:
$-74.42M
Rapporto P/E:
-9.2021
EPS:
-0.94
Flusso di cassa netto:
$150.93M
1 W Prestazione:
-6.89%
1M Prestazione:
-9.71%
6M Prestazione:
-62.33%
1 anno Prestazione:
-71.03%
Evolent Health Inc Stock (EVH) Company Profile
Nome
Evolent Health Inc
Settore
Industria
Telefono
571-389-6000
Indirizzo
800 NORTH GLEBE RD, SUITE 500, ARLINGTON
Confronta EVH con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
EVH
Evolent Health Inc
|
8.65 | 1.08B | 2.35B | -74.42M | 150.93M | -0.94 |
![]()
VEEV
Veeva Systems Inc
|
215.78 | 36.24B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
52.40 | 9.99B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
43.23 | 7.43B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
83.45 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.45 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-10 | Iniziato | Needham | Buy |
2024-12-03 | Reiterato | BTIG Research | Buy |
2024-11-08 | Downgrade | Stephens | Overweight → Equal-Weight |
2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
2024-08-09 | Aggiornamento | Truist | Hold → Buy |
2024-04-22 | Iniziato | Citigroup | Buy |
2024-03-01 | Iniziato | Oppenheimer | Outperform |
2024-01-03 | Iniziato | Barclays | Overweight |
2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
2023-10-16 | Iniziato | UBS | Buy |
2023-04-12 | Iniziato | Stephens | Overweight |
2022-11-01 | Iniziato | Truist | Hold |
2022-07-29 | Iniziato | RBC Capital Mkts | Outperform |
2022-03-30 | Iniziato | Guggenheim | Buy |
2021-11-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
2021-04-29 | Ripresa | JP Morgan | Neutral |
2021-01-07 | Iniziato | BTIG Research | Buy |
2020-07-06 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-06-05 | Downgrade | Goldman | Buy → Neutral |
2020-06-02 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2018-10-05 | Ripresa | Leerink Partners | Outperform |
2018-06-04 | Iniziato | Piper Jaffray | Overweight |
2018-04-24 | Ripresa | JP Morgan | Neutral |
2017-09-20 | Iniziato | KeyBanc Capital Mkts | Overweight |
2017-06-02 | Iniziato | Robert W. Baird | Outperform |
2017-03-14 | Iniziato | Oppenheimer | Outperform |
2017-01-13 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
2016-10-28 | Ripresa | JP Morgan | Overweight |
2016-08-05 | Reiterato | FBR Capital | Outperform |
2016-07-26 | Iniziato | Jefferies | Buy |
2016-07-13 | Reiterato | FBR Capital | Outperform |
2016-03-29 | Iniziato | FBR Capital | Outperform |
2016-01-06 | Iniziato | Canaccord Genuity | Buy |
2015-06-30 | Iniziato | Goldman | Buy |
2015-06-30 | Iniziato | JP Morgan | Overweight |
2015-06-30 | Iniziato | Leerink Partners | Outperform |
2015-06-30 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
Mostra tutto
Evolent Health Inc Borsa (EVH) Ultime notizie
Evolent Health Nominates Shawn Guertin to Board - TipRanks
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors | EVH Stock News - GuruFocus
Evolent Names Shawn Guertin As New Independent Nominee For Election To Its Board Of Directors - marketscreener.com
Healthcare Finance Veteran Shawn Guertin Brings 40-Year Experience to Evolent Board Nomination - Stock Titan
Molina Healthcare, Encompass Health, RadNet, Evolent Health, and Ibotta Shares Are Falling, What You Need To Know - Yahoo Finance
Analysts’ Top Healthcare Picks: Evolent Health (EVH), Gilead Sciences (GILD) - The Globe and Mail
Evolent Health Insiders Placed Bullish Bets Worth US$1.35m - Yahoo
Evolent program achieves 20% reduction in use of low-value oncol - GuruFocus
Healthcare Breakthrough: Evolent Slashes Expensive Cancer Treatment Costs While Maintaining Care Quality - Stock Titan
Benign Growth For Evolent Health, Inc. (NYSE:EVH) Underpins Its Share Price - simplywall.st
Evolent To Release First Quarter 2025 Financial Results on Thurs - GuruFocus
Evolent Health (EVH) Price Target Lowered by Truist Analyst Amid Market Uncertainty | EVH Stock News - GuruFocus
Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025 - The Malaysian Reserve
The Analyst Verdict: Evolent Health In The Eyes Of 16 Experts - Benzinga
1 Growth Stock to Stash and 2 to Keep Off Your Radar - The Globe and Mail
Evolent Health price target lowered to $14 from $15 at Truist - TipRanks
Truist Cuts Price Target on Evolent Health to $14 From $15, Keeps Buy Rating - marketscreener.com
Indo-Asian News Service - Indo-Asian News Service (IANS)
Evolent Health Sets Q1 Earnings Date: Key Financial Results and Conference Details Ahead - Stock Titan
Evolent Health, Inc. (NYSE:EVH) Receives $17.71 Consensus Target Price from Brokerages - MarketBeat
KeyBanc sees PRVA acquisition of EVH’s MSSP as unlikely but instructive - Investing.com Australia
Evolent Health, Inc. (EVH): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo
20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
Is Evolent Health (EVH) About to Explode? - Insider Monkey
12 Stocks That Are About to Explode - Insider Monkey
Here’s What Challenged Evolent Health (EVH) Despite Strong Revenue Growth - Insider Monkey
Evolent Health (NYSE:EVH) shareholders have endured a 69% loss from investing in the stock a year ago - Yahoo Finance
When the Price of (EVH) Talks, People Listen - Stock Traders Daily
1 Healthcare Stock on Our Watchlist and 2 to Turn Down - The Globe and Mail
Evolent Health (EVH): Among Stocks Insiders Are Buying In March - Insider Monkey
Evolent Health Co-Founder Acquires 13% More Stock - simplywall.st
10 Stocks Insiders Are Buying In March - Insider Monkey
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR) - The Globe and Mail
Cardinal Health Adds Two Members to Its Board of Directors - HME Business
Commit To Buy Evolent Health At $7.50, Earn 22.1% Annualized Using Options - Nasdaq
Define Ventures Appoints Carolyn Magill as Venture Partner - Quantisnow
Healthcare Powerhouse Carolyn Magill Joins $800M Define Ventures Leadership Team - StockTitan
Evolent Health (NYSE:EVH) Given New $12.00 Price Target at JPMorgan Chase & Co. - Defense World
Evolent Health, Inc. (NYSE:EVH) Receives Average Rating of “Buy” from Analysts - Defense World
Evolent health director Brendan Springstubb acquires $139,050 in stock By Investing.com - Investing.com South Africa
Evolent Health director Keck Kim buys $99,497 in stock By Investing.com - Investing.com South Africa
Evolent Health director Glass Russell Monroe acquires $50,058 in stock By Investing.com - Investing.com South Africa
Beyond The Numbers: 18 Analysts Discuss Evolent Health Stock - Benzinga
Evolent health director Peter Grua acquires $99,470 in shares By Investing.com - Investing.com Australia
Evolent Health CEO Seth Blackley purchases $497,577 in stock By Investing.com - Investing.com South Africa
Evolent Health president Daniel McCarthy buys $99,470 in stock By Investing.com - Investing.com Canada
Evolent health director Diane Holder buys shares worth $25,517 By Investing.com - Investing.com South Africa
Evolent Health director Glass Russell Monroe acquires $50,058 in stock - Investing.com
Evolent Health director Craig Barbarosh buys $17,620 in stock By Investing.com - Investing.com South Africa
Evolent Health president Daniel McCarthy buys $99,470 in stock - Investing.com India
Evolent health director Diane Holder buys shares worth $25,517 - Investing.com India
Evolent Health Inc Azioni (EVH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):